Quarry LP’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Quarry LP’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-750	Closed	-$44.1K	–	2004
2023 Q4	$44.1K	Sell	750 -1,000	-57%	-$56.2K	0.01%	367
2023 Q3	$76.2K	Buy	+1,750	New	+$62.5K	0.02%	240

Other funds holding MRTX

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Quarry LP's MRTX Position: Q1 2024 in Review

Quarry LP sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 750 shares — an estimated $44.1K sold.

Quarry LP first reported a position in MRTX in Q3 2023 and held it in 2 quarters. The position peaked at $76.2K in Q3 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

Quarry LP reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Quarry LP sold 750 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $44.1K.
Quarry LP first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Quarry LP's Mirati Therapeutics, Inc. Common Stock position peaked at $76.2K in Q3 2023.
2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Quarry LP's 13F filing for Q1 2024, filed 15 May 2024.